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6on the ora, fauna and microbial population of the rhizosphere present in the agro ecosystem is split into sub-items. 
e sub-item D.11.1 looks into the eects of the GM plant on non-target organisms (or substitute species) that directly 
or indirectly interact with the crop by assessing the product expressed in the GM plant, the plant material and/or by 
planting the GM plant. e sub item D.11.2 looks into the eect of the GM plant on species and ecologic interactions 
relevant for the local agro ecosystem. e rst assessment refers to dierent approaches (laboratory bioassays, semi eld 
trials, or eld trials) to assess the risk hypothesis for pest resistant traits and their eect on non-target organisms. e 
second sub-item comprises all other information specically related to species and ecological interactions that could be 
relevant for the local agro ecosystem for a particular trait that have not been addressed in the rst item and must be ad-
dressed case-by-case. In relation to these points of the application form, last year we conducted a two-day meeting with 
experts on four relevant crops (soybean, maize, cotton and sugarcane) to analyze which are the valued entities (particular 
valued species, gilds of species or ecological interactions) in the Argentina’s agro ecosystem for each of these crops. 
Another new issue in the amended regulations is the introduction of the Previous Consultation Instance (ICP in 
Spanish). is is an evaluator-applicant exchange mechanism that aims to clarify some of the information to be included 
in the form and provide details of the criteria to be used in the application. is instance is optional and designed for the 
benet of the applicant rather than an instance of debate of regulatory criteria. 
e evidence to be provided by the applicant for the non-target organisms risk assessment must entail: the setting of test-
able risk hypotheses, the denition of the criteria for appropriate selection of test species and ecological functional group, 
the laboratory and eld studies results with an appropriate experimental design and the estimation of risk/safety based on 
conclusions of these studies. Some specic issues are taken into account for the information submitted and those must 
be consistent with the hypothesis to be tested. ese issues include: the mode and spectrum of action of the expressed 
proteins and biochemical interactions, the exposure pathway and the level of exposure. In all cases, the evidence provided 
must be relevant, accurate, complete and reliable. Regarding reliability, those studies that use validated or standardized 
methods and/or are conducted under good laboratory practices (GLP) as well as peer-reviewed literature and also those 
studies based on consensus documents of international organizations are considered among reliable sources of informa-
tion to pursue a risk analysis.
 %UD]LO
Fernando Valicente, Ph.D., EMBRAPA, Brazil
In Brazil, Law Nº 11.105, of 24 March 2005 regulates items II, IV and V of Paragraph 1 of Article 225 of the Federal 
Constitution, provides for safety norms and inspection mechanisms for activities that involve genetically modied or-
ganisms (GMOs) and their by-products, implements the National Biosafety Council (CNBS), restructures the National 
Biosafety Technical Commission (CTNBio), provides for the National Biosafety Policy (PNB), revokes Law Nº 8.974, 
of 5 January 1995, Provisional Measure Nº 2.191-9, of 23 August 2001, and Arts. 5, 6, 7, 8, 9, 10 and 16 of Law Nº 
10.814, of 15 December 2003, and provides for other measures. e Brazilian legislation includes one law, two decrees, 
seven communications, CNBS resolutions, and nine normative resolutions. Normative Resolution No 05, of March 
12, 2008, gives provisions on rules for commercial release of Genetically Modied Organisms and their derivatives, and 
includes the norms on non-target organisms.
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In Article Nº 1, the law provides for safety norms and inspection mechanisms for the construction, culture, production, 
manipulation, transportation, transfer, import, export, storage, research, marketing, environmental release and discharge 
of GMOs and their by-products, guided by the drive for attaining scientic development in the biosafety and biotech-
nology area, the protection of life and human beings, of animal and plant health, and the compliance with the principal 
of environmental precaution. e Annex IV governs the Environment Risk Assessment and gives provisions on rules 
for commercial release of GMOs and their derivatives. ese rules include plants, organisms used for biological control, 
and invertebrate animals. 
7e rst part of these rules includes the plants.
A) PLANTS: Negative and positive eects to target and non-target organisms, that may take place with the released 
GMO, listing the species assessed, reason of the selection and techniques used to explain the impacts;
e second part of these rules includes all the organisms used for biological control including information about the 
non-target organisms.
B) ORGANISMS USED FOR BIOLOGICAL CONTROL: Seven basic pieces of information must be given by the 
applicant:
1. Target species of biological control and direct eects of GMO on such species compared with the eects on the 
parental organism;
2. Spectrum of organisms susceptible to the GMO and susceptibility of non-target organisms to the GMO, de-
scribing the criteria employed in the choice of organisms assessed;
3. Ways of GMO dispersion from one individual to another and factors that aect such dispersion;
4. Secondary eects that may happen to predators, preys, competitors, and parasites of the target species;
5. Metabolites produced by the GMO that may cause direct or indirect harmful eects on other species through 
concentration along the food chain;
6. Eects resulting from horizontal transfer to another organism, as the case may be;
7. Possible genetic modications that may happen in populations of the target organism as a result of the GMO 
use.
e third part of these rules includes all the invertebrate animals, including information about non-target organisms.
C) INVERTEBRATE ANIMALS: Eight basic pieces if information must be provided by the applicant:
1. GMO eects in the invertebrate’s food chain;
2. Possible production of new metabolites or toxins by the GMO that are able to cause harmful eects on the 
invertebrate’s parasites or predators;
3. Possible adverse eects of such GMO releasing in the local ecosystem;
4. Records of likely natural populations of the parental organism within Brazil and, in the a!rmative, discuss their 
eects, either benecial or harmful, to agriculture, environment, and public health;
5. Likelihood of the transgene to be transmitted to other species through non-conventional reproduction mecha-
nisms and, in the a!rmative, specify the transfer mechanism, listing the species;
6. Possible existence of experimental work on the phenotypic expression of the transgene in breeds of specic line-
ages modied with wild organisms. In the a!rmative, describe what these results were;
7. Change in distribution and abundance of natural populations by the possible integration of the transgene to the 
genic set of such populations, reporting on the possible eect of such change;
8. Mechanisms to be used to check dispersion of the GMO to other environments.
Normative resolution Nº 5 also rules the Post-Commercial Release Monitoring that is required in Brazil. Some basic 
information is also required regarding the non-target organisms.
1. e monitoring shall be conducted by the applicant with the purpose of oversee the eects resulting from com-
mercial release of a GMO and its derivatives to the environment and human and animal health.
82. e monitoring shall be conducted under strict observance of the principles of precaution, transparency, and 
scientic independence.
3. e monitoring shall be guided by internationally recognized scientic methodology and experimental designs 
adequate to the inferences to be made.
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e expression in plants of foreign genes of agronomic interest using modern transgenic technologies has provided dif-
ferent options to produce important genetically modied (GM) crops. Despite the high rate of adoption of GM crops, 
there are many concerns about the possible impact of these crops on the environment. e primary ecological concerns 
to the release of transgenic plants include those related to their possible invasiveness in ecosystems, out-crossing, hori-
zontal gene transfer, development of pest resistance and eects on non-target organisms (Conner et al., 2003). One of 
the primary concerns related to the adoption of insect resistant transgenic plants in the environment is the detrimental 
eect that these may pose on non-target organisms, including entomophagous arthropods (parasitoids and predators), 
which have an important function in regulating pests (Dutton et al., 2003). Eects of GM plants on non-target ento-
mophagous arthropods (predators and parasitoids) have been a major concern, as these organisms often play an impor-
tant role in natural pest regulation and are considered to be of economic value. Moreover, this group of organisms may 
be a good indicator of potential ecological impacts of transgenic plants as they belong to the third trophic level in the 
food chain (Groot and Dicke, 2002).
In Brazil, CTNBio members (regulators) are identied with their area of expertise. ese areas include: Crop Science 
and Environment, Human, and Animal Science. At least two regulators, depending on the dossier, are chosen to evaluate 
each GMO to be commercially released. Each dossier is evaluated case by case, and step by step. So, the possible eects 
of GM crops on non-target organisms follow the same rules and regulations.
According to the !e Economist (2010) in less than 30 years Brazil has turned itself from a food importer into one of 
the world’s great breadbaskets. It is the rst country to have caught up with the traditional “big ve” grain exporters 
(America, Canada, Australia, Argentina and the European Union). It is also the rst tropical food-giant; the big ve 
are all temperate producers. Due to a favorable climate, crops are planted throughout the year, and the farmers plant a 
second crop of corn or cotton called the safrinha. is new scheme of crop rotation is to rst plant a rain-fed crop, such 
as rice, soybean or maize, and then after these crops are harvested, plant a second crop of soybean, sorghum or even 
maize. Safrinha can also be dened as a farming strategy whereby the farmer takes advantage of a long tropical growing 
season to produce two crops in a single growing season, thereby maximizing revenue per acre. is new fact also causes 
concerns because (GM) crops are planted after (GM) crops, and insects are always exposed to crops even during the dry 
season. Usually insects may be exposed to the same Bacillus thuringiensis (Bt) genes, although dierent crops are planted. 
Farmers will have to plan a “gene rotation” instead of (GM) crop rotation.
It also should be considered that a GM crop is attacked by dierent insect pests; however, these insect pests may attack 
more than one crop and may be exposed to more than one toxin (in this specic case, Bt toxins), and these insect pests 
will be the target of parasitoids and predators. Other problem that may evolve is that the non-target organisms may be 
exposed to dierent toxins.
In Brazil post-commercial release monitoring is required by law, however, for some researchers it doesn’t make any sense, 
because to be commercially released, a GM crop must be fully studied and a dossier must be fully completed. So, when 
a GM crop is commercially available it is considered to be safe. On the other side, some researchers state that this moni-
toring is extremely important because some problems may occur in the future and the studies showed in the dossier are 
not enough. Some researchers recommend following these GM crops in the eld for many years. However, another issue 
that is not clear is how to address the post-commercial monitoring. Some important issues are still discussed such as:
9• If a GM crop is commercially approved and available in the market, there´s no need to do all the research again. 
Monitoring is dierent from research.
• Research on non-target organisms only if some questions arises. is research step should be GM crop and non-
target organism specic.
• Monitoring all possible eects in the environment, however it should be considered when evaluating and based 
on actual events. Scientic evidence should be considered.
• It should be considered that sampling and surveying large areas of commercially available GM crops is totally 
dierent from sampling eld trials.
• Monitoring should also consider the presence of single genes and stacked genes for insect pests. Possible interac-
tions should be considered.
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In the European Union (EU) a scientic opinion (SO) on the assessment of potential impacts of genetically modied 
(GM) plants on non-target organisms (NTOs), hereafter referred to as NTO SO, was issued in November 2010 (EFSA, 
2010a). e drafting of this document was an initiative undertaken by the European Food Safety Authority’s (EFSA) 
Panel on genetically modied organisms (GMOs), with the aim of providing guidance for risk assessors on assessing 
potential eects of GM plants on NTOs together with a rationale for data requirements. Issues to which special attention 
was paid were (i) criteria for non-target (NT) species selection and (ii) advice on testing approaches. 
ƌŝƚĞƌŝĂĨŽƌŶŽŶͲƚĂƌŐĞƚƐƉĞĐŝĞƐƐĞůĞĐƟŽŶ
Because not all NTOs present in the environment where a GM plant is grown can be tested in an environmental risk 
assessment (ERA), a representative subset of species (named “focal species” by EFSA) is selected. For the selection of 
focal species, a 4-step approach combining the strengths of two existing species selection approaches - the ecological and 
ecotoxicological approach - is proposed. 
Starting with problem formulation (step 1), functional groups (e.g., herbivores, pollinators, natural enemies, decompos-
ers) relevant to consider in the ERA are dened. Subsequently (step 2), NT species occurring in the GM plant’s receiving 
environment are categorised within the identied relevant functional groups. e GM plant’s receiving environment to 
be considered is the European agro-ecosystem (EFSA, 2010a). If relevant, endangered species also need to be listed. A 
rst prioritisation of species (step 3) is based on ecological criteria (e.g., species’ exposure to the GM plant, abundance, 
feeding habits, sensitivity to trait) as done in the ecological approach. When selecting the most appropriate species for 
testing (step 4) - the focal species - practical criteria (e.g., species’ availability and testability) considered in the ecotoxi-
cological approach are applied. In the end, this approach results in the selection of testable species belonging to relevant 
